Viewing Study NCT01637961


Ignite Creation Date: 2025-12-24 @ 12:19 PM
Ignite Modification Date: 2026-02-02 @ 6:33 PM
Study NCT ID: NCT01637961
Status: COMPLETED
Last Update Posted: 2019-07-23
First Post: 2012-07-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Uterine Corpus Sarcoma View
None Uterine Corpus Leiomyosarcoma View
Keywords: